glp-1 mash Incretin-based therapies in MASLD/MASH: from receptor agonists to dual and triple agonists Current Status of Glucagon-like Peptide-1
Description
[DOI] [PubMed] [Google Scholar] 9
While GLP-1 degradation is unaffected by kidney function, the clearance of both GLP-1, and to a greater extent its inactive metabolites, is delayed in patients with renal insufficiency [184]
PubMed Central PMCID: PMC4296509
doi: 10.1042/BSR20181995 35 FangBLiuFYuXLuoJZhangXZhangTet al
Moreover, women had a significantly increased likelihood of developing acne vulgaris after 1 year [79]
Artificially sweetened beverage use and long-term weight gain
